Literature DB >> 3406914

Cardiovascular function at rest and on exercise in patients with cryptogenic fibrosing alveolitis.

A Bush1, C M Busst.   

Abstract

Cardiovascular complications are common in fibrosing alveolitis, but there have been few physiological studies of the pulmonary circulation in this condition, and those that have been carried out have usually depended on right heart catheterisation. This paper reports non-invasive measurements of effective pulmonary blood flow, oxygen uptake, pulmonary arteriovenous oxygen content differences, and estimates of mixed venous oxygen saturation in 20 patients with histologically proved cryptogenic fibrosing alveolitis at rest and while exercising on a motorized treadmill. Results were compared with those of 20 age and sex matched normal subjects, at rest and at an arbitrarily chosen oxygen uptake of 0.75 l/min. The latter results were obtained by linear interpolation. Effective pulmonary blood flow was normal at rest, but oxygen dispatch to the tissues (blood flow x blood oxygen content) was significantly reduced at rest (mean reduction 190 (SD 68) ml/l/min; p less than 0.01) and at an oxygen uptake of 0.75 l/min (mean reduction 128 (50) ml/l/min; p less than 0.02), reflecting the presence of systemic arterial hypoxaemia. Pulmonary arteriovenous oxygen content differences were similar in patients and normal subjects, but mixed venous saturation was lower in the patients at rest (mean % reduction 6.8 (2.6); p less than 0.02) and at an oxygen uptake of 0.75 l/min (mean % reduction 9.6 (2.9); p less than 0.002). It is concluded that the supply of oxygen potentially available to the tissues is reduced at rest and during exercise in patients with fibrosing alveolitis and hence, by analogy with normal people exercising under hypoxic conditions, that pulmonary blood flow is inappropriately low in this condition. The low mixed venous oxygen saturation may contribute to the development of pulmonary hypertension in some patients. The rebreathing technique used in this study may be of use in monitoring treatment; it could be applied many times to the same patient, and might be a suitable way of following the response to pulmonary vasodilators.

Entities:  

Mesh:

Year:  1988        PMID: 3406914      PMCID: PMC461213          DOI: 10.1136/thx.43.4.276

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  The cardiac output in rest and work at low and high oxygen pressures.

Authors:  E ASMUSSEN; M NIELSEN
Journal:  Acta Physiol Scand       Date:  1955-12-22

2.  Distribution of ventilation-perfusion ratios in patients with interstitial lung disease.

Authors:  P D Wagner; D R Dantzker; R Dueck; J L de Polo; K Wasserman; J B West
Journal:  Chest       Date:  1976-02       Impact factor: 9.410

3.  Pulmonary mechanics in fibrosing alveolitis: the effects of lung shrinkage.

Authors:  G J Gibson; N B Pride
Journal:  Am Rev Respir Dis       Date:  1977-10

4.  Central haemodynamics during exercise in patients with restrictive pulmonary disease.

Authors:  J Widimsky; M Riedel; V Stanek
Journal:  Bull Eur Physiopathol Respir       Date:  1977 May-Jun

5.  The measurement of metabolic gas exchange and minute volume by mass spectrometry alone.

Authors:  N J Davies; D M Denison
Journal:  Respir Physiol       Date:  1979-02

6.  Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis.

Authors:  D McCarthy; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1973-02

7.  Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation.

Authors:  R A Bruce
Journal:  Ann Clin Res       Date:  1971-12

8.  Lung tissue volume and blood flow by rebreathing theory.

Authors:  M F Petrini; B T Peterson; R W Hyde
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-05

9.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-03       Impact factor: 9.139

10.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.

Authors:  J D Fulmer; W C Roberts; E R von Gal; R G Crystal
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

View more
  2 in total

1.  Cardiopulmonary response to oxygen therapy in hypoxaemic chronic airflow obstruction.

Authors:  J M Hunt; J Copland; C F McDonald; C E Barter; P D Rochford; R J Pierce
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 2.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.